Lakshmanan Krishnamurti

Contact Information:

Email: lakshmanan.krishnamurti@emory.edu

View Emory directory entry

School/Division:

Professor

SOMPI: BMT

Emory+Children's Ped Institute

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 16

  1. 1
  2. 2

Article

IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies

by Carlton Dampier; Wally R. Smith; Carrie G. Wager; Hae-Young Kim; Margaret C. Bell; Scott T. Miller; Debra L. Weiner; Caterina P. Minniti; Lakshmanan Krishnamurti; Kenneth I. Ataga; James Eckman; Lewis L. Hsu; Donna McClish; Sonja M. McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J. Telen; The Sickle Cell Disease Clinical Research Network (SCDCRN)

2013

Article

Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis A Randomized Controlled Trial

by Mark T. Gladwin; Gregory J. Kato; Debra Weiner; Onyinye C. Onyekwere; Carlton Dampier; Lewis Hsu; R. Ward Hagar; Thomas Howard; Rachelle Nuss; Maureen M. Okam; Carole K. Tremonti; Brian Berman; Anthony Villella; Lakshmanan Krishnamurti; Sophie Lanzkron; Oswaldo Castro; Victor R. Gordeuk; Wynona A. Coles; Marlene Peters-Lawrence; James Nichols

2011

Article

Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial

by Marlene H. Peters-Lawrence; Margaret C. Bell; Lewis L. Hsu; Ifeyinwa Osunkwo; Phillip Seaman; Miren Blackwood; Edouard Guillaume; Rita Bellevue; Lakshmanan Krishnamurti; Wally R. Smith; Carlton D Dampier; Caterina P. Minniti

2012

Article

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease

by Mark C. Walters; Laura M. De Castro; Keith M. Sullivan; Lakshmanan Krishnamurti; Naynesh Kamani; Christopher Bredeson; Donna Neuberg; Kathryn L. Hassell; Stephanie Farnia; Andrew Campbell; Effie Petersdorf

2016

Article

Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL (TM) Sickle Cell Disease Module

by Julie A. Panepinto; J. Paul Scott; Oluwakemi Badaki-Makun; Deepika S. Darbari; Corrie E. Chumpitazi; Gladstone E. Airewele; Angela M. Ellison; Kim Smith-Whitley; Prashant Mahajan; Sharada A. Sarnaik; T Charles Casper; Larry J. Cook; Julie Leonard; Monica L. Hulbert; Elizabeth C. Powell; Robert I. Liem; Robert Hickey; Lakshmanan Krishnamurti; Cheryl A. Hillery; David C. Brousseau

2017

Article

Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes

by Carlton Dampier; Wally R. Smith; Hae-Young Kim; Carrie Greene Wager; Margaret C. Bell; Caterina P Minniti; Jeffrey Keefer; Lewis Hsu; Lakshmanan Krishnamurti; A. Kyle Mack; Donna McClish; Sonja M. McKinlay; Scott T. Miller; Ifeyinwa Osunkwo; Phillip Seaman; Marilyn J. Telen; Debra L. Weiner

2011